돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 532495생성일: 2026년 10월 25일

Sodium hydride → 7-Bromo-4-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yloxy]-thieno[3,2-d]pyrimidine

https://huagongshe.com/reaction/532495

반응식

참여 물질

역할이름HCID투입량
반응물Sodium hydrideHCID 24758—
반응물Ammonium ChlorideHCID 25517—
반응물7-Bromo-4-chlorothieno[3,2-d]pyrimidineHCID 16655266—
반응물1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OLHCID 21897744—
용매DimethylformamideHCID 6228—
생성물7-Bromo-4-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yloxy]-thieno[3,2-d]pyrimidineHCID 6829933383%

반응 조건

온도0 °C

반응 단계

30 mg of 1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-ol was dissolved in 2 ml of N,N-dimethylformamide and cooled to 0° C. 9 mg of NaH was added to the mixture and stirred for 30 min. 50 mg of 7-bromo-4-chloro-thieno[3,2-d]pyrimidine was added to the mixture, heated to room temperature and stirred for 2 hr. The resulting mixture was added with aqueous ammonium chloride and extracted twice with ethyl acetate. The organic layer was washed with water, dried over anhydrous sodium sulfate, and concentrated under a reduced pressure to obtain a bubble residue. The resulting residue was crystallized in diethylether solvent to obtain 50 mg of the title compound as a white solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08853213B2
출처 데이터셋uspto-grants-2014_10
ORD IDord-d111b98d2e904b31a5c0bf3133ccae42
출처 메모uspto-grants-2014_10